
Non-Small Cell Lung Cancer Market: Valued at $18.8 Billion in 2024, Expected to Grow at 6.9% CAGR Through 2035
Non-Small Cell Lung Cancer Market grows as immunotherapy approvals by Merck & Bristol-Myers reshape global treatment pathways. CA, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- Non-Small Cell Lung Cancer (NSCLC) Market size was valued …